The effect of granulocyte-colony stimulating factor, decitabine, and busulfan–cyclophosphamide versus busulfan–cyclophosphamide conditioning on relapse in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia evolving from myelodysplastic syndrome undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised, phase 3 trial

Li Xuan, Min Dai, Erlie Jiang, Yu Wang, Fen Huang, Zhiping Fan, Na Xu, Danian Nie, Xinquan Liang, Hong Chen, Jieyu Ye, Pengcheng Shi, Hui Liu, Hua Jin, Ren Lin, Chen‐Hua Yan, Yu Zhang, Jing Sun, Mingzhe Han, Qifa Liu